UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

Journal of allergy and clinical immunology, 2014-04, Vol.133 (4), p.1032-1040

2014

Volltextzugriff (PDF)

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Journal of the American Academy of Dermatology, 2008, Vol.58 (1), p.106-115

2008

Volltextzugriff (PDF)

Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis

Journal of the American Academy of Dermatology, 2012-08, Vol.67 (2), p.245-256

2012

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Journal of the American Academy of Dermatology, 2008-05, Vol.58 (5), p.826-850

2008

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions

Journal of the American Academy of Dermatology, 2011-07, Vol.65 (1), p.137-174

2011

Volltextzugriff (PDF)

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials

JAMA : the journal of the American Medical Association, 2011-08, Vol.306 (8), p.864

2011

Volltextzugriff (PDF)

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 2. Psoriatic arthritis : Overview and guidelines of care for treatment with an emphasis on the biologics

Journal of the American Academy of Dermatology, 2008-05, Vol.58 (5), p.851-864

2008

Volltextzugriff (PDF)

A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach

Journal of the American Academy of Dermatology, 2009-07, Vol.61 (1), p.S1-S46

2009

Volltextzugriff (PDF)

Etanercept as Monotherapy in Patients with Psoriasis

The New England journal of medicine, 2003-11, Vol.349 (21), p.2014-2022

2003

Volltextzugriff (PDF)

Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial

Journal of the American Academy of Dermatology, 2005-03, Vol.52 (3), p.425-433

2005

Volltextzugriff (PDF)

A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis

Dermatology (Basel), 2006-01, Vol.213 (3), p.204

2006

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Volltextzugriff (PDF)

Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection

JAMA : the journal of the American Medical Association, 1992-11, Vol.268 (18), p.2541

1992

Volltextzugriff (PDF)

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis : Results from three randomized placebo-controlled. Phase III trials: Part I

Journal of cutaneous medicine and surgery, 2005-12, Vol.9 (6), p.303-312

2005

Volltextzugriff (PDF)

Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction

Journal of the American Academy of Dermatology, 1995-05, Vol.32 (5), p.730-733

1995

Volltextzugriff (PDF)

Practical guidelines for the long-term treatment of psoriasis with efalizumab

Journal of the American Academy of Dermatology, 2006-04, Vol.54 (4), p.A1-A1

LEONARDI, Craig L

2006

Volltextzugriff (PDF)

Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genome

Journal of cutaneous pathology, 1996-12, Vol.23 (6), p.576-581

1996

Volltextzugriff (PDF)

Efalizumab: An overview: Psoriasis for the clinician: A new therapeutics era (the Biologics) beckons

Journal of the American Academy of Dermatology, 2003, Vol.49 (2), p.S98-S104

LEONARDI, Craig L

2003

Volltextzugriff (PDF)

Concurrent herpes simplex and varicella-zoster infection in an immunocompromised patient

Journal of the American Academy of Dermatology, 1995-07, Vol.33 (1), p.126-129

1995

Volltextzugriff (PDF)

Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis: Topical Issues in the Management of Psoriasis

American journal of clinical dermatology, 2010, Vol.11, p.3-9

2010

Volltextzugriff (PDF)

Long-term management of plaque psoriasis with continuous efalizumab therapy: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Journal of the American Academy of Dermatology, 2006, Vol.54 (4)

2006

Volltextzugriff (PDF)

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis : Updated results from an ongoing trial: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Journal of the American Academy of Dermatology, 2006, Vol.54 (4)

2006

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis : 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Commentary

The Lancet (British edition), 2008, Vol.371 (9625)

2008

Volltextzugriff (PDF)

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Journal of the American Academy of Dermatology, 2006, Vol.54 (4)

2006

Volltextzugriff (PDF)

Etanercept monotherapy in patients with psoriasis : A summary of safety, based on an integrated multistudy database: The evolution of dermatologic therapeutics: Current uses of etanercept in psoriasis and other dermatoses

Journal of the American Academy of Dermatology, 2006, Vol.54 (3)

2006

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(41)
Humans
(33)
Dermatology
(31)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Psoriasis. Parapsoriasis. Lichen
(24)
Male
(20)
Female
(18)
Middle Aged
(18)
Adult
(16)
Psoriasis - Drug Therapy
(14)
Antibodies, Monoclonal - Therapeutic Use
(12)
Polymerase Chain Reaction
(11)
Psoriasis
(11)
Aged
(10)
Double-Blind Method
(10)
Antibodies, Monoclonal - Adverse Effects
(9)
Treatment Outcome
(9)
Infectious Diseases
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 2. Psoriatic arthritis : Overview and guidelines of care for treatment with an emphasis on the biologics

A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach

Etanercept as Monotherapy in Patients with Psoriasis

Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial

A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis : Results from three randomized placebo-controlled. Phase III trials: Part I

Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction

Practical guidelines for the long-term treatment of psoriasis with efalizumab

Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genome

Efalizumab: An overview: Psoriasis for the clinician: A new therapeutics era (the Biologics) beckons

Concurrent herpes simplex and varicella-zoster infection in an immunocompromised patient

Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis: Topical Issues in the Management of Psoriasis

Long-term management of plaque psoriasis with continuous efalizumab therapy: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis : Updated results from an ongoing trial: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis : 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Commentary

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis: Practical guidelines for the long-term treatment of psoriasis with efalizumab

Etanercept monotherapy in patients with psoriasis : A summary of safety, based on an integrated multistudy database: The evolution of dermatologic therapeutics: Current uses of etanercept in psoriasis and other dermatoses

Aktive Filter

Suchergebnisse filtern